Mode
Text Size
Log in / Sign up

HIV-2 diagnoses remain low in the United States, differentiation test use studied

HIV-2 diagnoses remain low in the United States, differentiation test use studied
Photo by Navy Medicine / Unsplash
Key Takeaway
Note: U.S. report finds HIV-2 diagnoses remain low; testing efficiencies may be possible.

A report from the United States describes trends in HIV-2 diagnoses and the use of the HIV-1/HIV-2 differentiation test. The study type, sample size, and specific methodology are not reported. The main finding is that diagnoses of HIV-2 remain low in the U.S. No specific numbers, effect sizes, or statistical measures for this outcome are provided. Safety, tolerability, and adverse event data are not reported for this descriptive analysis. The report notes no specific limitations in the provided data. The authors suggest the current HIV testing approach could be updated to streamline efficiencies. This is a descriptive report, not an interventional study, and it does not establish causality or compare specific testing strategies. The findings are based on observational data of unspecified scope and should be interpreted as a snapshot of current trends rather than evidence for changing practice.

Study Details

EvidenceLevel 5
PublishedJan 2020
View Original Abstract ↓
This report says diagnoses of human immunodeficiency virus (HIV)-2 remain low in the United States, and the current HIV testing approach could be updated to streamline efficiencies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.